NetScientific PLC NetScientific appoints Prof. Stephen Smith as NED (2646P)
17 Fevereiro 2016 - 5:00AM
UK Regulatory
TIDMNSCI
RNS Number : 2646P
NetScientific PLC
17 February 2016
NetScientific plc
NetScientific appoints Professor Stephen Smith as Non-Executive
Director
London, UK - 17 February 2016 - NetScientific plc
("NetScientific" or the "Group", AIM: NSCI), the transatlantic
biomedical and healthcare technology group, appoints Professor
Stephen Smith as Non-Executive Director, with effect from today.
Professor Smith will also join both the audit and remuneration
committees.
Stephen has held senior leadership roles in the NHS and
academia. He has had a long and distinguished career as a clinician
scientist, Head of Department, Dean and CEO with the Medical
Research Council, University of Cambridge, Imperial College, London
and Imperial College Healthcare NHS Trust.
He was responsible for the largest merger in the NHS, the
creation of the UK's first Academic Health Science Centre in 2007.
The merger brought together four London based NHS Trusts and
ultimately led to the creation of Imperial College Healthcare NHS
Trust, where Stephen served for four years as the first CEO. He
also retained his position as Dean of the Faculty of Medicine at
Imperial College, London and was responsible for facilitating the
commercialisation of life sciences and healthcare.
During his career, Stephen has spun two companies out of
Cambridge - Metris Therapeutics Ltd and GNI Group Ltd. GNI was
established as a start up in Japan in 2001 and successfully
achieved an Initial Public Offering (IPO) on the Tokyo Stock
Exchange six years later.
Stephen has extensive non-executive experience serving on the
Boards of the National Healthcare Group Singapore which developed
integrated care through nine polyclinics. In Australia, he was on
the Board of the Royal Melbourne Hospital and the Victorian
Comprehensive Cancer Centre, a $1billion project to create a fully
integrated cancer care facility that brings together an integrated
research, service and education offering to four million patients
in Victoria.
Commenting on the appointment, Sir Richard Sykes, Chairman of
NetScientific said: "Stephen's impressive leadership experience in
mergers and commercialisation internationally further strengthens
the Group. We look forward to welcoming Stephen to the team as we
continue to build our subsidiary companies towards developing new
technologies and concepts in healthcare management and diagnostics
to improve patient care and outcomes."
Other than the information provided below, which is being
disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules
for Companies, there is no further information required to be
disclosed pursuant to this rule. Stephen Kevin Smith, aged 64
years, has been a director of the following companies during the
five years preceding the date of this announcement:
Current directorships Past Directorships
---------------------------- ---------------------------------------
StephenKSmith Ltd London Genetics Limited
---------------------------- ---------------------------------------
GNI (UK) Limited The Nuffield Trust for Research
and Policy Studies in Health Services
---------------------------- ---------------------------------------
Metris Therapeutics Limited
---------------------------- ---------------------------------------
I C Consultants Limited
---------------------------- ---------------------------------------
- Ends -
Contact Details
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet, M.D., CEO
Investec (NOMAD and broker) Tel: +44 (0)20 7597 4000
Gary Clarence / Daniel Adams
Instinctif Partners Tel: +44 (0)20 7457 2020 Email:
Melanie Toyne-Sewell / Jayne Crook netscientific@instinctif.com
/ Rosanna Forrest
About NetScientific
NetScientific is a biomedical and healthcare technology group
that funds and develops technologies that offer transformative
benefits to people's lives and society through improved diagnosis,
prognosis and treatment.
For more information, please visit the website at
www.netscientific.net.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOADGGDDXGBBGLL
(END) Dow Jones Newswires
February 17, 2016 02:00 ET (07:00 GMT)
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024